Table 3.
Threshold fecal calprotectin (μg/g) | Sensitivity (95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | PLR (95% CI) | |||||
---|---|---|---|---|---|---|---|---|---|---|
A: Inflammatory bowel disease (IBD) or abnormal GI tract vs. functional disease | ||||||||||
20 | 0.89 | (0.83–0.93) | 0.49 | (0.44–0.53) | 0.32 | (0.28–0.37) | 0.94 | (0.91–0.96) | 1.73 | (1.57–1.91) |
50 | 0.79 | (0.71–0.85) | 0.74 | (0.70–0.77) | 0.45 | (0.39–0.52) | 0.93 | (0.90–0.95) | 3.02 | (2.57–3.54) |
70 | 0.73 | (0.65–0.80) | 0.80 | (0.76–0.83) | 0.50 | (0.44–0.57) | 0.92 | (0.89–0.94) | 3.66 | (3.03–4.43) |
100 | 0.70 | (0.62–0.77) | 0.87 | (0.84–0.90) | 0.60 | (0.52–0.67) | 0.91 | (0.89–0.93) | 5.42 | (4.27–6.87) |
B: IBD vs. functional disease | ||||||||||
20 | 0.99 | (0.93–1.00) | 0.49 | (0.44–0.53) | 0.24 | (0.20–0.28) | 1.00 | (0.98–1.00) | 1.92 | (1.77–2.09) |
50 | 0.97 | (0.90–0.99) | 0.74 | (0.70–0.77) | 0.37 | (0.31–0.44) | 0.99 | (0.98–1.00) | 3.70 | (3.20–4.27) |
70 | 0.97 | (0.90–0.99) | 0.80 | (0.76–0.83) | 0.44 | (0.37–0.51) | 0.99 | (0.98–1.00) | 4.84 | (4.09–5.74) |
100 | 0.96 | (0.89–0.99) | 0.87 | (0.84–0.90) | 0.54 | (0.46–0.62) | 0.99 | (0.98–1.00) | 7.41 | (5.96–9.22) |